CORD-19:3c1f47a07aaf0e393dee9fbd08596a4b9f4f0a03 / 20186-20528
Annnotations
CORD-19-Sentences
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
TextSentencer_T189 | 0-342 | Sentence | denotes | Most isolates showed decreased susceptibility to tetracycline, minocycline, erythromycin, and quinupristin-dalfopristin (95%, 94%, 80%, 54%, respectively), and to a lesser extent to high-level of resistance (HLR) of streptomycin, nitrofurantoin, ciprofloxacin, HLR to gentamicin, chloramphenicol and ampicillin (52%, 33%, 32%, 21%, 11%, 10%). |
T87613 | 0-342 | Sentence | denotes | Most isolates showed decreased susceptibility to tetracycline, minocycline, erythromycin, and quinupristin-dalfopristin (95%, 94%, 80%, 54%, respectively), and to a lesser extent to high-level of resistance (HLR) of streptomycin, nitrofurantoin, ciprofloxacin, HLR to gentamicin, chloramphenicol and ampicillin (52%, 33%, 32%, 21%, 11%, 10%). |
CORD-PICO
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
p1_all87 | 49-119 | Intervention | denotes | tetracycline, minocycline, erythromycin, and quinupristin-dalfopristin |
p1_all88 | 182-264 | Outcome | denotes | high-level of resistance (HLR) of streptomycin, nitrofurantoin, ciprofloxacin, HLR |
p1_all89 | 268-310 | Intervention | denotes | gentamicin, chloramphenicol and ampicillin |
p2_i24 | 49-61 | Pharmacological | denotes | tetracycline |
p2_i25 | 63-74 | Pharmacological | denotes | minocycline |
p2_i26 | 76-88 | Pharmacological | denotes | erythromycin |
p2_i27 | 94-119 | Pharmacological | denotes | quinupristin-dalfopristin |
p2_i28 | 246-259 | Pharmacological | denotes | ciprofloxacin |
p2_i29 | 268-278 | Pharmacological | denotes | gentamicin |
p2_i30 | 280-295 | Pharmacological | denotes | chloramphenicol |
p2_i31 | 300-310 | Pharmacological | denotes | ampicillin |
CORD-19_Custom_license_subset
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T189 | 0-342 | Sentence | denotes | Most isolates showed decreased susceptibility to tetracycline, minocycline, erythromycin, and quinupristin-dalfopristin (95%, 94%, 80%, 54%, respectively), and to a lesser extent to high-level of resistance (HLR) of streptomycin, nitrofurantoin, ciprofloxacin, HLR to gentamicin, chloramphenicol and ampicillin (52%, 33%, 32%, 21%, 11%, 10%). |